H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Before you vote › Federal bills
H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
116th Congress · introduced 2019-04-08 · Health · Latest: Received in the Senate and Read twice and referred to the Committee on Finance.
federal
Follow this bill, step by step
- Where it came from: introduced 2019-04-08 · official record
- Who proposed it: Rep. Spanberger, Abigail Davis [D-VA-7] · what a sponsor is
- What happened next: 1 recorded vote in our records. Latest: House roll call 586 (2019): On Motion to Suspend the Rules and Pass, as Amended, HR2115 (2019-10-28), Passed. See all
- Where it stands now: Received in the Senate and Read twice and referred to the Committee on Finance. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Plain summary
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements. The bill also provides statutory authority for certain provisions of the CMS rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.
Congressional Research Service summary (Passed House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Source: Congressional Research Service summary (Passed House)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7] · 5 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Jodey C. Arrington (R-TX), Brendan F. Boyle (D-PA), Jefferson Van Drew (R-NJ), Elissa Slotkin (D-MI)
Recorded votes
- House roll call 586 (2019): On Motion to Suspend the Rules and Pass, as Amended, HR2115 (2019-10-28): Passed
Words on this page, explained (3)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
- Rulemaking
- The process agencies use to write regulations that carry out laws passed by Congress or a legislature. Usually an agency publishes a proposed rule, takes public comments, then publishes a final rule.
- Statute
- A written law passed by a legislature. A statute can be changed by a later law; changing a constitution needs an amendment.
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Passed House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-116hr2115.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr>
Record fed-us-cong116-hr2115 · catalog fed-us-congress-bills-cong116 · updated 2026-11-15 by psicol fed-bills-cong116